对omega-3脂肪酸的抗抑郁药反应的血蛋白质概况
Jesper Lindahl1, Miranda Stiernborg2, Filip Ventorp1
1Unit for Biological and Precision Psychiatry, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Psychiatry, Skåne University Hospital, Lund, Sweden.
Progress in neuro-psychopharmacology & biological psychiatry
|August 29, 2025
概括
欧米茄-3 脂肪酸 (n-3 PUFA) 具有抗抑郁作用,特别是在炎症患者中. 这项研究确定了特定的生物标志物,这些生物标志物随着治疗而变化,并预测了严重抑郁症 (MDD) 的反应.
科学领域:
- 神经科学
- 免疫学
- 代谢科学
背景情况:
- 欧米茄-3 脂肪酸 (n-3 PUFA) 越来越多地被认为具有潜在的抗抑郁作用.
- 在低度炎症患者中,n-3 PUFA 的抗抑郁作用可能更为明显,因炎症标志物升高而显现.
- 包括免疫代谢和神经营养途径在内的n-3PUFA抗抑郁作用的精确机制需要进一步研究.
研究的目的:
- 在患有重大抑郁症 (MDD) 和健康对照患者中研究炎症和心脏代谢生物标志物.
- 在MDD患者接受n-3PUFA治疗后,研究这些生物标志物的变化.
- 确定这些生物标志物与抗抑郁药对n-3PUFA治疗的反应之间的关联.
主要方法:
- 九十四名MDD患者在稳定的抗抑郁药治疗中接受了8周的n-3PUFA补充剂.
- 在患者 (治疗前和治疗后) 和76名健康对照中使用近距离延伸测定技术分析了血炎症和心脏代谢标志物.
- 治疗反应被定义为汉密尔顿抑郁评分尺度≥50%的降低,部分最小方程差异分析用于确定蛋白质水平的差异.
主要成果:
- 在MDD患者和对照患者之间,以及响应者和不响应者之间,观察到免疫代谢和神经营养生物标志物的基线水平有显著差异.
- 在n-3PUFA治疗后,与细胞间通信和神经变相关的某些生物标志物显著增加.
- 这些发现突出了与MDD和治疗反应相关的不同生物标志物概况.
结论:
- 这项研究为n-3PUFA的抗抑郁机制提供了新的见解,支持它们在调节免疫和代谢过程中的作用.
- 与没有反应者相比,治疗前免疫激活的证据表明个性化n-3PUFA治疗策略的潜力.
- 这些发现有助于了解n-3PUFA如何发挥作用,并可能为重大抑郁症的未来治疗方法提供信息.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Antidepressant Drugs: Overview
741
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
741
G-protein Coupled Receptors
121.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
121.2K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
563
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
563


